Latest Insider Transactions at Angiodynamics Inc (ANGO)
This section provides a real-time view of insider transactions for Angiodynamics Inc (ANGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANGIODYNAMICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANGIODYNAMICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2021
|
Wesley Johnson |
SELL
Payment of exercise price or tax liability
|
Direct |
3,171
-3.55%
|
$82,446
$26.43 P/Share
|
|
Jul 28
2021
|
Wesley Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
5,726
+6.02%
|
$80,164
$14.64 P/Share
|
|
Jul 28
2021
|
Dennis S Meteny |
SELL
Payment of exercise price or tax liability
|
Direct |
3,171
-2.69%
|
$82,446
$26.43 P/Share
|
|
Jul 28
2021
|
Dennis S Meteny |
BUY
Exercise of conversion of derivative security
|
Direct |
5,726
+4.63%
|
$80,164
$14.64 P/Share
|
|
Jul 26
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,105
-0.58%
|
$54,730
$26.1 P/Share
|
|
Jul 26
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-0.51%
|
$9,178
$26.1 P/Share
|
|
Jul 26
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-1.18%
|
$8,268
$26.1 P/Share
|
|
Jul 26
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-0.9%
|
$10,894
$26.1 P/Share
|
|
Jul 21
2021
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
2,952
+50.0%
|
-
|
|
Jul 21
2021
|
Richard C Rosenzweig SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,098
+18.02%
|
-
|
|
Jul 21
2021
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+21.41%
|
-
|
|
Jul 21
2021
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+16.95%
|
-
|
|
Jul 21
2021
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+4.87%
|
-
|
|
Jul 21
2021
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+5.49%
|
-
|
|
Jul 21
2021
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+11.92%
|
-
|
|
Jul 21
2021
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+11.84%
|
-
|
|
Jul 21
2021
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+6.42%
|
-
|
|
Jul 21
2021
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,189
+6.76%
|
-
|
|
Jul 21
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
4,388
+13.99%
|
-
|
|
Jul 21
2021
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
2,842
+5.74%
|
-
|
|
Jul 21
2021
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,058
+15.68%
|
-
|
|
Jul 21
2021
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,408
+9.74%
|
-
|
|
Jul 18
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-0.44%
|
$35,592
$24.76 P/Share
|
|
Jul 18
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-1.31%
|
$7,200
$24.76 P/Share
|
|
Jul 18
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-0.78%
|
$8,256
$24.76 P/Share
|
|
Jul 18
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-2.29%
|
$10,008
$24.76 P/Share
|
|
Jul 18
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-0.65%
|
$9,600
$24.76 P/Share
|
|
Jul 17
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,131
-0.63%
|
$51,144
$24.76 P/Share
|
|
Jul 17
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-1.13%
|
$6,288
$24.76 P/Share
|
|
Jul 17
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-0.76%
|
$8,136
$24.76 P/Share
|
|
Jul 17
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-1.59%
|
$7,056
$24.76 P/Share
|
|
Jul 17
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-0.57%
|
$8,496
$24.76 P/Share
|
|
Jul 14
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,622
-1.35%
|
$120,172
$26.43 P/Share
|
|
Jul 14
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
571
-2.41%
|
$14,846
$26.43 P/Share
|
|
Jul 14
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-1.11%
|
$13,000
$26.43 P/Share
|
|
Jul 14
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-3.35%
|
$16,640
$26.43 P/Share
|
|
Jul 14
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-2.03%
|
$33,384
$26.43 P/Share
|
|
Apr 15
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,080
-13.74%
|
$241,920
$24.21 P/Share
|
|
Apr 15
2021
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,625
+15.66%
|
$190,750
$14.07 P/Share
|
|
Apr 14
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
3,500
-15.48%
|
$80,500
$23.93 P/Share
|
|
Apr 01
2021
|
Howard W Donnelly |
SELL
Payment of exercise price or tax liability
|
Direct |
3,621
-3.75%
|
$83,283
$23.15 P/Share
|
|
Apr 01
2021
|
Howard W Donnelly |
BUY
Exercise of conversion of derivative security
|
Direct |
5,726
+5.6%
|
$80,164
$14.64 P/Share
|
|
Feb 03
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-0.87%
|
$10,013
$19.24 P/Share
|
|
Feb 01
2021
|
Richard C Rosenzweig SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 20
2021
|
Wesley Johnson |
SELL
Open market or private sale
|
Direct |
6,500
-7.7%
|
$117,000
$18.53 P/Share
|
|
Dec 18
2020
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-3.14%
|
$10,262
$14.29 P/Share
|
|
Oct 31
2020
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
849
-1.85%
|
$8,490
$10.62 P/Share
|